Long-term Progression-free Survival With Pemetrexed Plus Bevacizumab in NSCLC Patients.
Article in Cancer Diagnosis & Prognosis (May 2023)
The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.
A Systems Biology and LASSO-Based Approach to Decipher the Transcriptome–Interactome Signature for Predicting Non-Small Cell Lung Cancer
Article in Biology (November 2022)
Patient-reported outcomes from the randomized phase 3 CROWN study of first-line lorlatinib versus crizotinib in advanced ALK-positive non-small cell lung cancer
Article in Lung Cancer (November 2022)